MedPath

Clinical impact and treatment outcomes of irregular heart rhythm on human feelings, emotions and intellect

Not Applicable
Completed
Conditions
Atrial fibrillation
Psychological distress
Neurocognitive function
Mental Health - Anxiety
Mental Health - Depression
Mental Health - Other mental health disorders
Registration Number
ACTRN12618000062224
Lead Sponsor
Prof Jonathan Kalman
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
100
Inclusion Criteria

Paroxysmal and persistent atrial fibrillation
Able to give valid consent

Exclusion Criteria

Severe valvular heart disease
Patients treated for suicidal ideation
Patients being treated for severe depression, anxiety or mood disorders
Pre-existing neurological or clinically evident neurovascular condition
Anticipated difficulty with neurocognitive assessment (deafness, language difficulties)
Contraindication for systemic anticoagulation
Patients who sustain a new cerebrovascular accident during study period
Rheumatic mitral valve disease
Pregnancy

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Hospital emotional distress as measured using Hospital Anxiety and Depression Scale score[Baseline, 3, 6, 9 and 12 months (primary time point) after randomisation];Composite outcome of Cognitive ability as assessed by results of Trail Making tests A and B'[Baseline, 3, 6, 9, 12 (primary time point), 18 and 24 months ];Arrhythmia free survival at 12 months post catheter ablation. <br>Patients were followed up either face to face and via telephone at 3, 6, and 12 months post ablation. Intensive rhythm monitoring with either intracardiac monitoring (Implantable loop recorder or permanent pacemaker), or AliveCor twice daily was used to detect arrhythmia recurrences and estimate the AF burden. <br>[12 months post catheter ablation. ]
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath